February 13, 2014

After meeting for two days earlier this week, the Food and Drug Administration's Arthritis Advisory Committee and Drug Safety and Risk Management Advisory Committee voted 16-9 against changing the label of naproxen to highlight a lower cardiovascular risk profile as compared to other NSAIDs, according to published reports.

January 29, 2014

A pair of Food and Drug Administration advisory committees will be meeting Feb. 10 to talk about heart risks associated with use of NSAIDs and whether or not Bayer's Aleve (naproxen) carries a lower risk profile than other NSAIDs

July 24, 2012

Significant product recalls and the ongoing recession have driven consumer behavior change in the OTC aisle, according to a new report published Tuesday by Kline.

November 28, 2011

Bayer Healthcare on Monday announced its "Countdown to Holiday Cheer" sweepstakes in support of its Aleve brand.

April 28, 2011

The American Pain Foundation on Wednesday launched new information and resources on pain medication safety for acetaminophen and nonsteroidal anti-inflammatory drugs as part of its PainSafe educational initiative.

March 25, 2011

A pill developed by AstraZeneca and Pozen that combines a nonsteroidal anti-inflammatory drug with a proton-pump inhibitor was well-tolerated in patients with osteoarthritis, according to a new study.

November 29, 2010

Perrigo on Monday launched a store-brand version of Bayer Healthcare’s Aleve Liquid Gels, 220 mg.

August 2, 2010

Victory Pharma has finished acquiring virtually all the assets of MiddleBrook Pharmaceuticals, Victory said Tuesday....

May 2, 2010

The Food and Drug Administration has approved a drug by AstraZeneca and Pozen for treating...